ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,352, issued on Oct. 21, was assigned to CuraSen Therapeutics Inc. (San Carlos, Calif.).
"Beta adrenergic agonist and methods of using the same" was invented by Anthony P. Ford (San Carlos, Calif.), Wei Chen (Saratoga, Calif.), David Scott Carter (Sunnyvale, Calif.) and Jiaxin Yu (Foster City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with an adrenergic receptor. In certain embodiments of the methods disclosed herein, the methods include administering to the subject a compound as disclosed herein and a peripher...